Capitalnumbers Infotech has announced its 14th AGM on September 29, 2026, proposing a Rs 1 per share final dividend. Key agenda items include the reallocation of Rs 11.46 crore in unutilized IPO funds toward acquiring Epitomecloud Technology and broadening the scope for investment in subsidiaries. Shareholders will vote on these resolutions via e-voting.
Capitalnumbers Infotech Sets AGM Date and Proposes IPO Fund Pivot
Capitalnumbers Infotech has scheduled its 14th Annual General Meeting for September 29, 2026, where shareholders will vote on a Rs 1 per share dividend and a significant strategic reallocation of IPO capital.
Reader Takeaway: Shareholders will weigh a Rs 1 dividend against the repurposing of unutilized IPO funds for a new acquisition.
What just happened
The company is seeking shareholder approval to change the usage of funds raised during its January 2025 IPO. Specifically, it plans to divert Rs 1,146.46 lakhs from 'Issue Related Expenses' to fund the acquisition of a 100% stake in Epitomecloud Technology Private Limited. Additionally, the company is broadening the scope of its 'Investment in Subsidiary' allocation to include its newly proposed wholly-owned subsidiary, Epitome Cloud Inc.
Why this matters
The reallocation of Rs 11.46 crore toward the Rs 40 crore acquisition of Epitomecloud Technology signals a strategic shift in capital deployment. While the IPO total remains unchanged, the pivot suggests the company is prioritizing inorganic growth to bolster its technological capabilities. The proposed final dividend of Rs 1 per share, with a record date of September 22, 2026, provides immediate cash flow clarity for retail investors.
What changes now
The management has confirmed that the total amount earmarked for these objects will not increase. The balance of the acquisition cost for Epitomecloud Technology will be covered through internal accruals. Shareholders must vote on these Special Resolutions, with remote e-voting enabled between September 26 and September 28, 2026.
What to track next
Investors should monitor the outcome of the e-voting process, specifically whether the strategic shift to acquire Epitomecloud receives the necessary threshold of shareholder approval. Furthermore, updates on the actual closure of the acquisition will be key to understanding the integration timeline and potential impact on future earnings.
